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Available online 5 April 2007AbstractOxidative stress, excitotoxicity and mitochondrial dysfunction play synergistic roles in neurodegeneration. Maintenance of thiol homeostasis is
important for normal mitochondrial function and dysregulation of protein thiol homeostasis by oxidative stress leads to mitochondrial dysfunction
and neurodegeneration. We examined the critical roles played by the antioxidant, non-protein thiol, glutathione and related enzyme, glutaredoxin
in maintaining mitochondrial function during excitotoxicity caused by b-N-oxalyl amino-L-alanine (L-BOAA), the causative factor of
neurolathyrism, a motor neuron disease involving the pyramidal system. L-BOAA causes loss of GSH and inhibition of mitochondrial complex
I in lumbosacral cord of male mice through oxidation of thiol groups, while female mice are resistant. Reducing GSH levels in female mice CNS by
pretreatment with diethyl maleate or L-propargyl glycine did not result in inhibition of complex I activity, unlike male mice. Further, treatment of
female mice depleted of GSH with L-BOAA did not induce inhibition of complex I indicating that GSH levels were not critical for maintaining
complex I activity in female mice unlike their male counterpart. Glutaredoxin, a thiol disulfide oxidoreductase helps maintain redox status of
proteins and downregulation of glutaredoxin results in loss of mitochondrial complex I activity. Female mice express higher levels of glutaredoxin
in certain CNS regions and downregulation of glutaredoxin using antisense oligonucleotides sensitizes them to L-BOAA toxicity seen as
mitochondrial complex I loss. Ovariectomy downregulates glutaredoxin and renders female mice vulnerable to L-BOAA toxicity as evidenced by
activation of AP1, loss of GSH and complex I activity indicating the important role of glutaredoxin in neuroprotection. Estrogen protects against
mitochondrial dysfunction caused by excitotoxicity by maintaining cellular redox status through higher constitutive expression of glutaredoxin in
the CNS. Therapeutic interventions designed to upregulate glutaredoxin may offer neuroprotection against excitotoxicity in motor neurons.
# 2007 Elsevier Ltd. All rights reserved.
Keywords: b-N-Oxalyl-amino-L-alanine; Complex I; Neurodegeneration; Estrogen; Oxidative stress; Motor neuron disease1. Introduction
Brain has a high rate of metabolism and is dependent on
energy supplies from mitochondria for normal functioning.
Minor alterations in mitochondrial function can lead to
oxidative damage and deleterious pathological changes in
neurons (Dugan et al., 1995; Beal, 1995). Glutathione, a non-
protein thiol plays an important role in the detoxification of* Corresponding author at: National Brain Research Centre, Nainwal Mode,
Manesar 122050, India. Tel.: +91 124 2338929; fax: +91 124 2338928.
E-mail address: vijir@nbrc.ac.in (V. Ravindranath).
0197-0186/$ – see front matter # 2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.neuint.2007.03.008reactive oxygen species in brain. The deficiency of glutathione
leads to mitochondrial dysfunction (Sriram et al., 1998; Jha
et al., 2000). Generally in brain (Shivkumar and Ravindranath,
1992; Shivkumar et al., 1995) and brain mitochondria in
particular (Ravindranath and Reed, 1990) oxidative stress
results in extensive formation of protein glutathione mixed
disulfides (PrSSG) at available cysteine residues in proteins.
Although glutathionylation of proteins is seen in certain cells of
non-neural origin (Schuppe et al., 1992; Rokutan et al., 1994), it
is more pronounced in brain, presumably because extrusion of
GSSG, as routinely observed in other tissues such as lung and
liver is not always seen in brain (Ravindranath and Reed, 1990;
Shivkumar et al., 1995). Formation of PrSSG can potentially
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groups resulting in opening of the mitochondrial permeability
transition pore, an event that can be blocked by the thiol
reductant, dithiothreitol (Petronilli et al., 1994). These studies
indicate that maintenance of thiol homeostasis is important for
proper mitochondrial function.
Excitotoxic mechanisms have been proposed to play a role
in the pathogenesis of various degenerative disorders (Tapia
et al., 1999) including Huntington’s, Parkinson’s disease and
amylotrophic lateral sclerosis (ALS). Mitochondria play a
critical role in excitotoxic injury presumably by accumulating
large amounts of calcium and generating reactive oxygen
species (Lopachin, 1999). Thus, a close association and
synergistic interplay exists between excitotoxicity, mitochon-
drial dysfunction, oxidative stress and neurodegeneration.
Glutaredoxin (also known as thioltransferase; Grx1), a
cytosolic thiol disulfide oxidoreductase, specifically and
efficiently reduces glutathionylated proteins to protein thiols
utilizing reducing equivalents of NADPH (Gravina and
Mieyal, 1993; Chrestensen et al., 2000). We have shown that
Grx1 is essential for maintenance of mitochondrial complex I
activity and downregulation of Grx1 results in loss of complex
I activity (Kenchappa and Ravindranath, 2003) through
oxidation of critical thiol groups in complex I subunits.
In the present study we have used an excitatory amino acid
as a model neurotoxin to examine the relative contribution of
GSH and Grx1 in maintaining mitochondrial function during
toxic insult. b-N-Oxalyl amino-L-alanine (L-BOAA, also
known as b-N-oxalyl-b-diamino propionic acid, b-ODAP;
Spencer et al., 1986) is present in the chickling pea from the
plant Lathyrus sativus and is known to be the causative factor
for a type of motor neuron disease called neurolathyrism.
Degeneration of anterior horn cells and loss of axons in the
pyramidal tracts in lumbar spinal cord is seen in humans
affected by neurolathyrism (Cohn and Streifler, 1981). L-BOAA
is an agonist of the AMPA subtype of glutamate receptor
(Pearson and Nunn, 1981; Ross et al., 1989). Oxidative stress
and mitochondrial dysfunction, primary events in glutamate
neurotoxicity (Schinder et al., 1996) are major contributors to
L-BOAA induced toxicity. L-BOAA causes glutathione (GSH)
loss and increase in protein glutathione mixed disulfides
(PrSSG) in lumbosacral cord of male mice (Kenchappa et al.,
2002) resulting in selective inhibition of mitochondrial
complex I, a major component of the mitochondrial electron
transport chain, due to oxidation of critical thiol groups (Sriram
et al., 1998). In humans, the incidence of neurolathyrism is
more common in men, while women are less prone to the
disease although quantity of the chickling pea consumed is not
significantly different (Roy, 1988; Norris et al., 1993). The
animal model of L-BOAA toxicity mimics site-specificity and
the gender difference seen in humans (Sriram et al., 1998). We
have examined the molecular mechanisms underlying estrogen-
mediated neuroprotection against mitochondrial dysfunction
seen following L-BOAA administration with a view to
understand the mechanisms underlying the pathogenesis of
motor neuron loss in this disease with particular reference to
protein thiol homeostasis since there are indications thatglutaredoxin is regulated by estrogen in certain CNS regions
(Kenchappa et al., 2004).
2. Experimental procedures
2.1. Materials
L-BOAAwas obtained from Research Biochemicals (Natick, MA). Cystei-
nyl glutathione disulfide was purchased from Toronto Research Chemicals
(Toronto, Canada). Ubiquinone 1 was obtained as a gift from Eisai Pharma-
ceutical Company (Tokyo, Japan). Northern blot analysis was performed using
digoxigenin-labeling kit from Roche Biochemicals (Mannheim, Germany).
Antibody to Grx1 was obtained from Lab Frontiers Life Science Institute
(Seoul, Korea). All other chemicals and reagents were of analytical grade and
were obtained from Sigma Chemical Company (St. Louis, MO) or Qualigens
(Mumbai, India).
2.2. Animals
Male and female Swiss albino mice (1–3 months old) were obtained from
the Animal Research Facility, National Institute of Mental Health and Neu-
rosciences and National Brain Research Centre. Animals had free access to
pelleted diet (Lipton, Calcutta, India) and water, ad libitum. All animal
experiments were carried out according to National Institutes of Health guide-
lines for care and use of laboratory animals. All efforts were made to minimize
animal suffering, to reduce number of animals used and to employ alternatives
to in vivo techniques, if available. Female mice (3–4 weeks old) were anesthe-
tized with ether and an incision of about 2–3 cm was made in the lower
abdomen for ovariectomy. Ovaries were removed carefully and the abdomen
was sutured. In sham-operated mice, a similar incision was made and the
abdomen was sutured without removing ovaries. Ovariectomized and sham-
operated mice were used for experimentation after 2 months. During sacrifice,
atrophy of uterus and lack of ovaries were examined to ensure success of
ovariectomy. Serum estrogen levels were measured using radioimmuno assay
(Rao et al., 1984). L-BOAA (10 mg/kg body weight; s.c.) was dissolved in
normal saline prior to use and animals were sacrificed 1 h later. In some
experiments L-propargyl glycine (PPG; 100 mg/kg body weight) was adminis-
tered to mice 6 h prior to L-BOAA and animals were sacrificed 1 h later.
Diethylmaleate was administered subcutaneously at a dose of 430 mg/kg body
weight and mice were sacrificed 2 h later. Control animals received vehicle
alone.
2.3. Processing of tissue
Tissue was homogenized in 0.25 M sucrose and centrifuged at 1000  g for
10 min to obtain post-nuclear supernatant, which was centrifuged again at
14,000  g for 30 min to obtain the mitochondrial pellet. The post-mitochon-
drial supernatant was used for assay of Grx1 activity. Mitochondrial pellet was
suspended in sucrose (0.25 M), and freeze-thawed for assay of complex I. The
homogenate was centrifuged at 100,000  g for 30 min to obtain cytosol and
used for estimation of cystathionine-g-lyase activity. For the assay of total GSH
(GSH + GSSG) the frozen tissue was homogenized in 9 volumes of 100 mM
potassium phosphate buffer (pH 7.4) containing 1 mM EDTA. An aliquot of
homogenate was added to an equal volume of 5-sulfosalicylic acid (10%, w/v),
mixed and centrifuged at 10,000  g for 10 min and the supernatant was used
for estimation of total GSH. Protein concentration was estimated by a dye-
binding method (Bradford, 1976).
2.4. Estimation of glutathione (GSH + GSSG)
Total glutathione (GSH + GSSG) was estimated by the enzymatic recycling
method (Sriram et al., 1998). The reaction mixture consisted of 100 mM
potassium phosphate buffer (pH 7.4) containing 0.8 mM dithiobisnitrobenzoic
acid and 0.5 U/ml glutathione reductase in a total volume of 0.44 ml. The acid-
soluble tissue supernatant (0.01 ml) prepared as described above was added.
The reaction was initiated by adding 0.05 ml of 1.2 mM NADPH. The increase
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generated using a known amount of GSSG.
2.5. Assay of cystathionine-g-lyase
Cystathionine-g-lyase activity was measured in cytosol prepared from
mouse brain according to Heinonen (1973). The reaction mixture (total
volume 0.5 ml) containing cytosolic protein from brain (2 mg), 100 ml
Tris–HCl buffer (5 mM) and 10 ml of pyridoxal 50-phosphate (1 mM) was
considered as blank. The test sample contained all the above and 10 ml of L-
cystathionine (2 mM), as substrate. Samples were incubated for 2 h and the
reaction was terminated by placing the tubes in ice-water bath at 4 8C.
Dithiothreitol (5 mM, 10 ml) was added to each tube to reduce all cystine.
Ninhydrin reagent was added to all the tubes and heated in boiling water bath
for 10 min. Tubes were cooled under tap water, the absorbance of the pink
coloured complex was measured at 560 nm by spectrophotometric method
(Gaitonde, 1967) using cysteine as standard.
2.6. Assay of NADH ubiquinone oxidoreductase (complex I) and
Grx1 activities
Complex I activity was assayed in mitochondrial preparations as rotenone-
sensitive NADH-ubiquinone oxidoreductase as described in detail (Sriram
et al., 1998). Grx1 activity was estimated in post-mitochondrial supernatant
using cysteinyl glutathione disulfide as substrate (Balijepalli et al., 1999).
2.7. Downregulation of Grx1 expression in mice using antisense
oligonucleotides
Antisense and sense phosphorothionate end-capped oligonucleotides (21
mer) originating from the start codon of Grx1 cDNA (antisense: ATG GCT
CAGGAGTTTGTGAAC; sense: TACCGAGTCCTCAAACACTTA) were
injected intrathecally into mice at 100 mg/dose, twice at 12 h intervals. The
downregulation of Grx1 was examined by measuring enzyme activity 12 h after
the last injection of oligonucleotides. L-BOAA (10 mg/kg body weight) was
administered 11 h after the second injection of the end-capped oligonucleotides,
and the animals were killed 1 h after L-BOAA. The lumbosacral segments of the
spinal cord were dissected out and the activities of complex I and Grx1 were
assayed as described earlier.
2.8. Northern blotting
Total RNA from lumbosacral cord of mice was extracted using TRI reagent.
CNS regions from three animals were pooled for each sample preparation. Total
RNA was separated electrophoretically and transferred to positively charged
nylon membranes by capillary transfer, UV cross-linked and hybridized with
digoxigenin-labeled cRNA prepared using the cDNA to Grx1 (Balijepalli et al.,
1999). The blots were washed, incubated with antibody to digoxigenin con-
jugated with alkaline phosphatase and bands were visualized using chromo-
genic substrate for alkaline phosphatase. The relative intensity of the bands was
estimated using densitometry.
2.9. Immunoblot analysis
Post-mitochondrial supernatant from lumbosacral cord was subjected to
SDS-PAGE gel electrophoresis, transferred to nitrocellulose membrane, and
incubated with the antibody to Grx1, followed by incubation with anti-rabbit
IgG labeled with alkaline phosphatase. Immunostained bands were detected
using nitroblue tetra zolium and 5-bromo-4-chloro-3-indolyl phosphate as
chromogens.
2.10. Electrophoretic mobility shift assays (EMSA)
Nuclear extracts were prepared from lumbosacral cord of vehicle and L-
BOAA-treated, male, female, sham-operated and ovariectomized female mice
(Korner et al., 1989). CNS regions from three animals were pooled for eachsample preparation. Activation of AP1 was studied using EMSA as described in
detail (Kenchappa et al., 2002).
Statistical analysis was performed using Student’s t-test or ANOVA fol-
lowed by Student–Newman Keul’s or Dunnet’s test as appropriate.
3. Results
3.1. Loss of GSH does not lead to mitochondrial
dysfunction in female mice
Diethyl maleate (DEM) depletes GSH levels in cells through
covalent modification of the thiol group in GSH thus rendering
it unavailable as an anti-oxidant. Pretreatment of both male and
female mice with DEM for 2 h decreased GSH levels
significantly both in male and female mice cortex. The loss
of GSH resulted in complex I inhibition only in male mice but
not in female mice (Fig. 1a). Propargyl glycine (PPG) inhibits
cystathionine g-lyase (the rate-limiting enzyme in the conver-
sion of methionine to cysteine) resulting in impaired synthesis
of cysteine and decreased GSH levels. Pretreatment of mice
with PPG results in lowered GSH levels in male and female
mice cortex. However, the loss of complex I activity seen as a
result of lowered GSH levels was again seen only in the male
but not in the female mice (Fig. 1b). These results clearly
indicate that GSH loss does not induce mitochondrial complex I
dysfunction in female mice.
3.2. Differential response of male, female and
ovariectomized mice to L-BOAA
We wanted to investigate if loss of GSH caused by prior
inhibition of cystathionine g-lyase by PPG conferred vulner-
ability to L-BOAA toxicity in female mice. Female mice were
pretreated with PPG for 6 h followed by 1 h exposure of L-
BOAA and GSH level was estimated in lumbosacral cord. PPG
alone caused GSH loss (28%), but there was no loss of GSH
following administration of L-BOAA alone indicating that
female mice were resistant to L-BOAA induced GSH loss.
Further, pretreatment with PPG followed by L-BOAA did not
cause any additional loss of GSH in female mice lumbosacral
cord (Fig. 2a). The administration of PPG and L-BOAA, alone
or in combination did not affect the complex I activity
indicating the resistance of female mice to L-BOAA toxicity
(Fig. 2a).
In male mice a sustained decrease in complex I activity was
seen from 15 min to 24 h in the lumbosacral cord following a
single dose of L-BOAA (Fig. 2b) while it was unaffected in
females. Ovariectomized mice were similar to male mice and
complex I activity showed sustained inhibition in the
lumbosacral cord (Fig. 2b). We also examined GSH levels
after a single dose of L-BOAA. In ovariectomized mice, GSH
levels decreased significantly 0.5 and 1 h after L-BOAA
treatment (Fig. 2c) in a manner similar to that seen in male
mice, while sham-operated female mice were unaffected. Basal
GSH levels were similar in sham-operated and ovariectomized
mice indicating that GSH levels were not influenced by
estrogen. AP1 is a redox sensitive transcription factor whose
Fig. 1. Loss of GSH does not lead to mitochondrial dysfunction in female mice. Mice were pretreated for 2 h with diethyl maleate (430 mg/kg body weight, s.c.) or
6 h with L-propargyl glycine (100 mg/kg body weight, s.c.) and sacrificed later. Control animals received vehicle alone. GSH levels expressed as nanomoles GSH/mg
protein and complex I activity expressed as nanomoles of NADH oxidized/min/mg protein were estimated in the cortex of male and female mice. Values are
mean  S.E.M. (n = 3 animals). Asterisk indicates values significantly different from controls ( p < 0.002).
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perturbation (Galter et al., 1994). AP1 activation was
significantly increased in lumbosacral cord of male and
ovariectomized mice, 15 min after L-BOAA administration,
whereas, it was unaffected in female mice (Fig. 2d). In
ovariectomized mice, a series of events starting with AP1
activation, loss of GSH and complex I activity was seen, while
they remained unchanged in sham-operated female.
3.3. Downregulation of Grx1 by antisense oligonucleotides
in female mice results in loss of complex I
We downregulated Grx1 in female mouse brain by
intrathecal administration of antisense phosphorothionate
end-capped oligonucleotides (21 mer) originating from the
start codon of Grx1 cDNA. This resulted in loss of Grx1 activity
in lumbosacral cord (28% decrease) of female mice (Fig. 3).
Downregulation of Grx1, per se resulted in loss of complex I
indicating the Grx1 plays an important role to maintain
complex I activity in female mice.
3.4. Female mice are sensitized to L-BOAA toxicity by
downregulation of Grx1
Downregulation of Grx1 in female mice results in loss of
complex I and sensitizes female mice to L-BOAA toxicity. In
female mouse brain, intrathecal administration of antisense
nucleotides resulted in 28% decrease in Grx1 activity in
lumbosacral cord and abolished the neuroprotection seen infemale mice against L-BOAA toxicity, as observed by the
pronounced decrease in complex I activity in lumbosacral cord
(Fig. 4).
3.5. Constitutive expression of Grx1 in male, female and
ovariectomized mice
The basal level of Grx1 (measured as mRNA, protein and
enzyme activity) was higher in the lumbosacral cord of female
mice compared to males (Fig. 5a). Ovariectomy decreased the
basal expression of Grx1 in lumbosacral cord indicating that the
expression of Grx1 was regulated by estrogen (Fig. 5b–d). We
examined the effect of ovariectomy on Grx1 activity in several
CNS regions and non-CNS tissues, such as liver and kidney.
Removal of ovaries resulted in significant loss of Grx1 activity
in all the CNS regions examined, with the exception of
thalamus and hippocampus (Fig. 5e). Further, Grx1 activity was
unaffected in liver and kidney.
4. Discussion
Maintenance of protein thiol homeostasis is critical for
mitochondrial complex I activity since it contains several
cysteine residues (Dupuis et al., 1991) and facile glutathionyla-
tion of thiol groups in the 51 and 75 kDa subunits of complex by
oxidants, such as GSSG results in inhibition of the enzyme
activity (Taylor et al., 2003). The 75 kDa subunit of complex I
is also a substrate for caspase 3 (Ricci et al., 2004).
Glutathionylation of complex I subunits could result in
Fig. 2. Differential response of male, female and ovariectomized mice to L-BOAA. Female mice were pretreated for 6 h with L-propargyl glycine (100 mg/kg body
weight, s.c.) prior to administration of L-BOAA (10 mg/kg body weight, s.c.) and sacrificed 1 h later. Control animals received vehicle alone. GSH levels as
nanomoles of GSH/mg protein and complex I activity as nanomoles of NADH oxidized/min/mg protein were estimated in the lumbosacral cord of female mice. (a)
Values are mean  S.E.M. (n = 3 animals). Asterisk indicates values significantly different from controls ( p < 0.002). Mice were administered single dose of L-
BOAA and sacrificed after 0.5, 1 and 24 h. Complex I activity was estimated in lumbosacral cord of male, female and ovariectomizedmice. Values are mean  S.E.M.
(n = 6 animals). Asterisk indicates values significantly different from corresponding vehicle treated controls ( p < 0.002). (b) L-BOAAwas administered and animals
were killed 0.5 or 1 h later. (c) Total GSH (GSH + GSSG) levels were estimated in lumbosacral cord of male, female and ovariectomized mice. GSH levels are
expressed as nanomoles of GSH/mg protein. Values are mean  S.E.M. (n = 6 animals). Male, female, sham-operated and ovariectomized mice were administered a
single dose of L-BOAA and sacrificed after 15 min. Electrophoretic mobility shift assay performed using nuclear extracts from lumbosacral cord. (d) Lanes 1 and 2
represent control and L-BOAA treated male mice, similarly lanes 3 and 4 represent control and L-BOAA treated female mice. Sham-operated control and L-BOAA
treated femalemice are represented in lanes 5 and 6 similarly ovariectomizedmice are represented in lane 7 and lane 8. Lane containing only oligonucleotides without
nuclear extract is represented in (F). (e) A representative densitometric analyses of EMSA are depicted from male and female, sham-operated and ovariectomized
female mice treated with L-BOAA. The lanes in EMSA are represented in the same chronological order as shown in the densitometric quantitation. Values are
mean  S.E.M. (n = 3 individual experiments).
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vicious cycle of oxidative damage in mitochondria. Further,
studies using PC12 cells have shown increased ROS leads to
mitochondrial dysfunction and necrosis, indicating such
mechanism may play a role in neurodegenerative disorders
(Luo et al., 2005). Depletion of GSH in PC12 cells bydownregulating g-glutamyl cysteine synthetase (the rate-
limiting enzyme for GSH synthesis) resulted in the loss of
mitochondrial complex I activity but other components of the
electron transport chain were unaffected (Davey et al., 1998;
Jha et al., 2000). These studies have clearly demonstrated the
selective vulnerability of mitochondrial complex I to oxidative
Fig. 3. Downregulation of Grx1 by antisense oligonucleotides in female mice
results in loss of complex I activity. Female mice were treated with sense (S) or
antisense (AS) oligonucleotides to Grx1 (200 mg) through intrathecal admin-
istration in two doses at 12 h intervals. Grx1 activity expressed as nanomoles of
NADPH/min/mg protein and complex I activity expressed as nanomoles of
NADH/min/mg protein were measured in lumbosacral cord. Values are
mean  S.D. (n = 5–6 animals). Asterisk (*) indicates values significantly
different from vehicle-treated control ( p < 0.05).
Fig. 4. Downregulation of Grx1 by antisense oligonucleotides sensitizes female
mice to L-BOAA-mediated mitochondrial dysfunction. Female mice were
treated with sense (S) or antisense (AS) oligonucleotides to Grx1 (200 mg)
through intrathecal administration in two doses at 12 h intervals. L-BOAAwas
administered 11 h after the second dose and animals were killed 1 h later. Grx1
activity expressed as nanomoles of NADPH/min/mg protein and complex I
activity expressed as nanomoles of NADH/min/mg protein were measured in
lumbosacral cord. Values are mean  S.D. (n = 5–6 animals). Asterisk (*)
indicates values significantly different from vehicle-treated control, while
asterisks (**) indicate values significantly different from the corresponding
group of animals not treated with L-BOAA ( p < 0.05).
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present study we examined the critical roles played by GSH vis-
a`-vis cytosolic Grx1 in maintaining mitochondrial function
using the animal model of L-BOAA that not only causes
selective toxicity in the motor cortex and lumbar sacral cord but
also mimics the gender difference seen in humans.
Interestingly, in the present study we noticed that depletion
of total GSH in female CNS did not result in mitochondrial
dysfunction as seen in males. Loss of even 30% of GSH in
lumbar sacral cord of males resulted in equivalent loss of
complex I activity while depletion of up to 50% of GSH in
females did not affect the enzyme activity. In contrast, in female
mice downregulation of Grx1 (20% decrease) resulted in
significant loss of complex I (30% loss), which was furtherpotentiated when L-BOAAwas co-administered (Figs. 3 and 4).
Thus, Grx1 activity but not GSH levels seem critical for the
neuroprotection seen in female mice. It is also possible that
mitochondrial GSH levels are better maintained in female mice
and are resistant to depletion compared to males. This may also
contribute to the lack of inhibition of complex I in females
following depletion of GSH, although constitutive gender
difference is not seen in GSH levels.
Cysteine, the rate-limiting factor in GSH synthesis is made
available to the neurons through the glutamate/cystine Xc

antiporter and the glutamate EAAC1 transporter (Sato et al.,
2005). Excess extracellular glutamate hinders the uptake of
cystine leading to decreased GSH levels in neurons (Murphy
et al., 1989) and EAAC1 knockout mice have lowered GSH
levels (Aoyama et al., 2006). Thus, availability of cysteine is
critical for maintaining GSH levels, which is also substantiated
by the fact that inhibition of cystathionine g-lyase by propargyl
glycine leads to loss of GSH (Fig. 1; Diwakar and
Ravindranath, 2007). The current study underscores the
importance of Grx1, which effectively recycles GSH by
reducing the mixed disulfides to the protein thiols. While loss of
GSH in female mice has no effect on the neuroprotection, a
small perturbation of Grx1 leads to mitochondrial dysfunction
and renders them vulnerable to the excitotoxin. These studies
Fig. 5. Constitutive expression of Grx1 in male, female and ovarectomized mice. (a) Grx1 activity was estimated in lumbosacral cord of male, female and
ovariectomized mice and expressed as nanomoles of NADPH/min/mg protein. Values are mean  S.E.M. (n = 6 animals). (b) A representative Northern blot,
corresponding 18S rRNA band of the total RNA and the densitometric analyses of the Northern blot representing relative intensity of hybridized bands from
lumbosacral cord male and female mice are depicted. Each lane was loaded with 10 mg of total RNA. Values are mean  S.E.M. (n = 3 individual experiments). (c)
Represents a similar experiment as described above using ovariectomized and sham-operated female mice. Each lane was loaded with 15 mg of total RNA. Values are
mean  S.E.M. (n = 3 individual experiments). (d) A representative immunoblot blot and densitometric analyses of the immunoblot representing the relative intensity
of the immunostained Grx1 protein in lumbosacral cord of ovariectomized and sham-operated female mice. Protein (15 mg) was loaded in each lane. The lanes are
represented in the same chronological order as shown in the densitometric quantitation. Values are mean  S.E.M. (n = 3 animals). Asterisk indicates values
significantly different from corresponding controls ( p < 0.005). (e) Grx1 activity was measured in motor cortex (MC), striatum (ST), cerebellum (CE), midbrain
(MB), pons (PO), thalamus (TH), hippocampus (HP), cervical cord (CC), thoracic cord (TC), lumbosacral cord (LSC), liver (LIV) and kidney (KD) from sham-
operated female (sham) and ovariectomized (ova) mice. Values are mean  S.E.M. (n = 6 animals). Asterisk indicates values significantly different from sham-
operated females ( p < 0.005).
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functional integrity of the CNS.
Constitutively, Grx1 is expressed in higher levels in
lumbosacral cord of female mice, the regions affected by L-
BOAA (Fig. 5). Ovariectomy downregulates Grx1 in CNS
regions affected by L-BOAA as well as in other regions, such
as, striatum and cerebellum. However, in thalamus and
hippocampus no difference is noted between sham-operated
and ovariectomized animals indicating that Grx1 is not
regulated by estrogen in these brain regions. Further,
ovarietomy has no effect on Grx1 activity in liver and kidney
indicating that it is not regulated by estrogen in these tissues.
Individual brain regions respond very differently and
potentially differential levels of Grx1 expression or turnover
may contribute to determine the final outcome of estrogen-
mediated neuroprotection, in addition to other factors. The
antioxidant effect of estrogen in pharmacological doses has
been demonstrated earlier, we now provide evidence, in vivo,of the regulation of expression of critical anti-oxidant
enzymes, such as Grx1 by estrogen in CNS indicating that
the neuroprotective effects of estrogen may be mediated
through maintenance of redox status of critical proteins
(Fig. 6).
Gender difference in Grx1 expression in lumbosacral cord
was not completely abolished by ovariectomy. Although Grx1
activity decreased significantly in lumbosacral cord of female
mice following ovariectomy (25% decrease compared to sham-
operated females), it was higher than the activity seen in male
mice. This may be due to the fact that serum estrogen levels in
ovariectomized animals (10.0  4.9 pg/ml serum) were
reduced by 60% compared to the sham-operated female mice
(27.0  1.2 pg/ml serum). The presence of circulating estrogen
synthesized by non-ovarian tissues such as, adrenal gland may
account for the above.
Grx1 is a cytosolic enzyme and its role in maintaining
mitochondrial function is as yet unclear. However, several
Fig. 6. Estrogen regulates Grx1 expression, which in turn maintains redox
status of critical thiols of mitochondrial complex I. L-BOAA generates oxidative
stress leading to protein thiol oxidation resulting in mitochondrial dysfunction
seen as loss of complex I activity. Grx1 helps maintain the redox status of
proteins and downregulation of Grx1 results in loss of complex I activity.
Estrogen regulates Grx1 expression and upregulation of Grx1 by estrogen
prevents mitochondrial dysfunction by maintaining redox status of critical thiol
groups.
L. Diwakar et al. / Neurochemistry International 51 (2007) 37–4644mitochondrial membrane proteins that are critically involved in
maintenance of mitochondrial membrane potential (MMP) are
sensitive to redox perturbation. For example, adenine nucleo-
tide translocator (ANT), a specific carrier for exchange of
adenosine triphosphate (ATP) and ADP is a major player in the
maintenance of MMP. Oxidation of critical cysteine residue
(cys 56) of ANT by thiol cross linkers leads to mitochondrial
membrane permeabilization and cell death (Costantini et al.,
2000). ANT also interacts with another component of outer
membrane the voltage dependent anion channel (VDAC/porin).
Alteration in mitochondrial membrane potential and opening of
the mitochondrial permeability transition pore (White and
Reynolds, 1996) through voltage-dependent channels is
directly associated with an oxidation–reduction sensitive
dithiol (Lieven et al., 2003), and the cross-linking of the
sulfhydryl groups increases the probability of the mitochondrial
permeability transition pore opening, an event that can be
blocked by the thiol reductant, dithiothreitol (Petronilli et al.,
1994; Vieira et al., 2000). Decrease in de-glutathionylation
capability in the cytosol can potentially lead to perturbation of
the redox status of other hitherto unidentified mitochondrial
outer membrane proteins which may influence complex I
activity.
The mitochondrial form of glutaredoxin (Grx2; Gladyshev
et al., 2001; Lundberg et al., 2001) that shares only 36%
sequence identity to Grx1 (Park and Levine, 1997) could also
play a role in the reduction of glutathionylated complex I.
While Grx1 seems to play an important role in preserving
mitochondrial integrity thereby preventing complex I loss,
Grx2 could potentially restore complex I activity in
mitochondria through deglutathionylation. However, we did
not find any gender difference in expression of Grx2 (data not
shown).Estrogen is known to regulate the expression of several
neuroprotective genes. These include neurotrophic factors such
as nerve growth factor, brain derived neurotrophic factor
(BDNF), neurotrophin 3, their receptors TrkA–C and p75, and
insulin-like growth factor 1 (IGF1) (Sohrabji et al., 1995;
Toran-Allerand et al., 1999; Blurton-Jones et al., 1999). The
promoter region of anti apoptotic genes, Bcl2 and BclXL
contains ERE and estrogen enhances their transcription in vitro
(Pike, 1999; Singer et al., 1999). A third group of genes
regulated by estrogen are some structural proteins in neurons.
Estrogen affects the expression of neurofilament proteins,
microtubulin-associated proteins, TAU and GAP43 (Scoville
et al., 1997). In addition to neurotrophic factors, structural
proteins and anti-apoptotic factors; thiol antioxidants and their
related enzymes, such as thiol disulfide oxido-reductases
including Grx1 may represent a fourth class genes that are
regulated by estrogen in the CNS and are involved in
neuroprotection particularly those related to mitochondrial
dysfunction.
The studies described herein suggest that estrogen protects
against mitochondrial dysfunction by maintaining cellular
redox status through higher constitutive expression of thiol
disulphide oxido-reductase such as, glutaredoxin in the CNS
(Fig. 6). Up regulation of glutaredoxin, in vivo may offer a
therapeutic target for neuroprotection against excitotoxicity in
motor neurons.
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